These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 10101326

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
    Murata H, Kusuzaki K, Takeshita H, Hirata M, Hashiguchi S, Emoto K, Ashihara T, Hirasawa Y.
    Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Angiography of histopathologic variants of synovial sarcoma.
    Lois JF, Fischer HJ, Mirra JM, Gomes AS.
    Acta Radiol Diagn (Stockh); 1986; 27(4):449-54. PubMed ID: 3022559
    [Abstract] [Full Text] [Related]

  • 32. [201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors].
    Tsuda T, Kubota M, Yoshida S, Shibata M, Wakabayashi J, Obata H, Matsuyama T, Usui M, Ishii S.
    Kaku Igaku; 1994 Dec; 31(12):1477-94. PubMed ID: 7861647
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Prognostic factors of bone and soft tissue sarcomas].
    Furuse K.
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2050-5. PubMed ID: 3293534
    [Abstract] [Full Text] [Related]

  • 37. Preoperative transarterial embolization using gelatin sponge for hypervascular bone and soft tissue tumors in the pelvis or extremities.
    Shimohira M, Nagai K, Hashizume T, Nakagawa M, Ozawa Y, Sakurai K, Matsushita Y, Yamada S, Otsuka T, Shibamoto Y.
    Acta Radiol; 2016 Apr; 57(4):457-62. PubMed ID: 26082444
    [Abstract] [Full Text] [Related]

  • 38. MRI surveillance after resection for primary musculoskeletal sarcoma.
    Watts AC, Teoh K, Evans T, Beggs I, Robb J, Porter D.
    J Bone Joint Surg Br; 2008 Apr; 90(4):484-7. PubMed ID: 18378924
    [Abstract] [Full Text] [Related]

  • 39. The role of radionuclide bone-scanning in determining the resectability of soft-tissue sarcomas.
    Enneking WF, Chew FS, Springfield DS, Hudson TM, Spanier SS.
    J Bone Joint Surg Am; 1981 Feb; 63(2):249-57. PubMed ID: 7462282
    [Abstract] [Full Text] [Related]

  • 40. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.
    Taki J, Sumiya H, Higuchi T, Tsuchiya H, Takazawa K, Tomita K, Tonami N.
    J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.